Papillomavirus type 16 E6/E7 and human telomerase reverse transcriptase in esophageal cell immortalization and early transformation

Cancer Letters

Volumn 245, Issue 1-2, 2007, Pages 184-194

  Zhang, Hao ^a   Jin, Yuesheng ^b   Chen, Xuehua ^a   Jin, Charlotte ^b   Law, Simon ^a   Tsao, Sai Wah ^a   Kwong, Yok Lam ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Esophageal cancer; HPV; Telomerase

Indexed keywords

AURORA A KINASE; PROTEIN E6; PROTEIN E7; PROTEIN P16; PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN; TELOMERASE REVERSE TRANSCRIPTASE; AURORA KINASE; CADHERIN; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; NOCODAZOLE; ONCOGENE PROTEIN E7, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; PROTEIN P16INK4A; PROTEIN SERINE THREONINE KINASE; RASSF1 PROTEIN, HUMAN; REPRESSOR PROTEIN; TELOMERASE; TERT PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CARCINOGENESIS; CELL CYCLE G2 PHASE; CELL IMMORTALIZATION; CONTROLLED STUDY; DNA METHYLATION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CANCER; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE LOCUS; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; MALIGNANT TRANSFORMATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; CELL CULTURE; CELL CYCLE; CELL TRANSFORMATION; CYTOLOGY; DRUG EFFECT; EPITHELIUM CELL; ESOPHAGUS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; PATHOLOGY; WESTERN BLOTTING;

HUMAN PAPILLOMAVIRUS;

BLOTTING, WESTERN; CADHERINS; CELL CYCLE; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; EPITHELIAL CELLS; ESOPHAGUS; FLOW CYTOMETRY; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; NOCODAZOLE; ONCOGENE PROTEINS, VIRAL; PROTEIN-SERINE-THREONINE KINASES; REPRESSOR PROTEINS; TELOMERASE; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 33845751069     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2006.01.005     Document Type: Article

References (41)

1. International Agency for Research on Cancer, Cancer Incidence in Five Continents, vol. 7, IARC Science Publishers, Lyon, France, 1997, p. 1240.
2. Matsubara T., Yamada K., and Nakagawa A. Risk of second primary malignancy after esophagectomy for squamous cell carcinoma of the thoracic esophagus. J. Clin. Oncol. 21 (2003) 4336-4341
3. Pohl H., and Welch H.G. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J. Natl Cancer Inst. 97 (2005) 142-146
4. Lagergren J., Bergstrom R., Lindgren A., and Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N. Engl. J. Med. 340 (1999) 825-831
5. Wabinga H.R., Colebunders B., Odida M., Ocama P., and Colebunders R. Risk factors for and types of oesophageal cancer. Lancet 364 (2004) 2018
6. Han C., Qiao G., Hubbert N.L., Li L., Sun C., Wang Y., et al. Serologic association between human papillomavirus type 16 infection and esophageal cancer in shaanxi province. China J. Natl Cancer Inst. 88 (1996) 1467-1471
7. Dillner J., Knekt P., Schiller J.T., and Hakulinen T. Prospective seroepidemiological evidence that human papillomavirus type 16 infection is a risk factor for oesophageal squamous cell carcinoma. Br. Med. J. 311 (1995) 1346
8. Bjorge T., Hakulinen T., Engeland A., Jellum E., Koskela P., Lehtinen M., et al. A prospective, seroepidemiological study of the role of human papillomavirus in esophageal cancer in Norway. Cancer Res. 57 (1997) 3989-3992
9. Lagergren J., Wang Z., Bergstrom R., Dillner J., and Nyren O. Human papillomavirus infection and esophageal cancer: a nationwide seroepidemiologic case-control study in Sweden. J. Natl Cancer Inst. 91 (1999) 156-162
10. Si H.X., Tsao S.W., Poon C.S., Wang L.D., Wong Y.C., and Cheung A.L. Viral load of HPV in esophageal squamous cell carcinoma. Int. J. Cancer 103 (2003) 496-500
11. Si H.X., Tsao S.W., Poon C.S., Wong Y.C., and Cheung A.L. Physical status of HPV-16 in esophageal squamous cell carcinoma. J. Clin. Virol. 32 (2005) 19-23
12. Morales C.P., Lee E.L., and Shay J.W. In situ hybridization for the detection of telomerase RNA in the progression from barrett's esophagus to esophageal adenocarcinoma. Cancer 83 (1998) 652-659
13. de Kok J.B., Ruers T.J., van Muijen G.N., van Bokhoven A., Willems H.L., and Swinkels D.W. Real-time quantification of human telomerase reverse transcriptase mRNA in tumors and healthy tissues. Clin. Chem. 46 (2000) 313-318
14. Shammas M.A., Koley H., Beer D.G., Li C., Goyal R.K., and Munshi N.C. Growth arrest, apoptosis, and telomere shortening of Barrett's-associated adenocarcinoma cells by a telomerase inhibitor. Gastroenterology 126 (2004) 1337-1346
15. Jin Y., Jin C., Law S., Chu K.M., Zhang H., Strombeck B., et al. Cytogenetic and fluorescence in situ hybridization characterization of clonal chromosomal aberrations and CCND1 amplification in esophageal carcinomas. Cancer Genet. Cytogenet. 148 (2004) 21-28
16. Tsao S.W., Wang X., Liu Y., Cheung Y.C., Feng H., Zheng Z., et al. Establishment of two immortalized nasopharyngeal epithelial cell lines using SV40 large T and HPV16E6/E7 viral oncogenes. Biochim. Biophys. Acta 1590 (2002) 150-158
17. INK4A- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status. Mol. Cell Biol. 22 (2002) 5157-5172
18. Chu P.W., Cheung W.M., and Kwong Y.L. Differential effects of 9-cis, 13-cis and all-trans retinoic acids on the neuronal differentiation of human neuroblastoma cells. Neuroreport 14 (2003) 1935-1939
19. Choo C.K., Ling M.T., Suen C.K., Chan K.W., and Kwong Y.L. Retrovirus-mediated delivery of HPV16 E7 antisense RNA inhibited tumorigenicity of CaSki cells. Gynecol. Oncol. 78 (2000) 293-301
20. Chan E.C., Lam S.Y., Tsang K.W., Lam B., Ho J.C., Fu K.H., et al. Aberrant promoter methylation in Chinese patients with non-small cell lung cancer: patterns in primary tumors and potential diagnostic application in bronchoalevolar lavage. Clin. Cancer Res. 8 (2002) 3741-3746
21. Chan A.O., Lam S.K., Wong B.C., Wong W.M., Yuen M.F., Yeung Y.H., et al. Promoter methylation of E-cadherin gene in gastric mucosa associated with helicobacter pylori infection and in gastric cancer. Gut 52 (2003) 502-506
22. Zhang H., Tsao S.W., Jin C., Strombeck B., Yuen P.W., Kwong Y.L., and Jin Y. Sequential cytogenetic and molecular cytogenetic characterization of an SV40T-immortalized nasopharyngeal cell line transformed by Epstein-Barr virus latent membrane protein-1 gene. Cancer Genet. Cytogenet. 150 (2004) 144-152
23. Jin Y., Zhang H., Tsao S.W., Jin C., Lv M., Strombeck B., et al. Cytogenetic and molecular genetic characterization of immortalized human ovarian surface epithelial cell lines: consistent loss of chromosome 13 and amplification of chromosome 20. Gynecol. Oncol. 92 (2004) 183-191
24. Nakamura T., Hayashi K., Ota M., Ide H., Takasaki K., and Mitsuhashi M. Expression of p21(Waf1/Cip1) predicts response and survival of esophageal cancer patients treated by chemoradiotherapy. Dis. Esophagus 17 (2004) 315-321
25. Nie Y., Liao J., Zhao X., Song Y., Yang G.Y., Wang L.D., and Yang C.S. Detection of multiple gene hypermethylation in the development of esophageal squamous cell carcinoma. Carcinogenesis 23 (2002) 1713-1720
26. Sarbia M., Geddert H., Klump B., Kiel S., Iskender E., and Gabbert H.E. Hypermethylation of tumor suppressor genes (p16INK4A, p14ARF and APC) in adenocarcinomas of the upper gastrointestinal tract. Int. J. Cancer 111 (2004) 224-228
27. Ohbu M., Kobayashi N., and Okayasu I. Expression of cell cycle regulatory proteins in the multistep process of oesophageal carcinogenesis: stepwise over-expression of cyclin E and p53, reduction of p21(WAF1/CIP1) and dysregulation of cyclin D1 and p27(KIP1). Histopathology 39 (2001) 589-596
28. Smeds J., Berggren P., Ma X., Xu Z., Hemminki K., and Kumar R. Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: the CDKN2A (p16(INK4a) and p14(ARF)) and p53 genes are major targets for inactivation. Carcinogenesis 23 (2002) 645-655
29. Bischof O., Nacerddine K., and Dejean A. Human papillomavirus oncoprotein E7 targets the promyelocytic leukemia protein and circumvents cellular senescence via the Rb and p53 tumor suppressor pathways. Mol. Cell Biol. 25 (2005) 1013-1024
30. Fujita Y., Sakakura C., Shimomura K., Nakanishi M., Yasuoka R., Aragane H., et al. Chromosome arm 20q gains and other genomic alterations in esophageal squamous cell carcinoma, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization. Hepatogastroenterology 50 (2003) 1857-1863
31. Tong T., Zhong Y., Kong J., Dong L., Song Y., Fu M., et al. Overexpression of aurora-a contributes to malignant development of human esophageal squamous cell carcinoma. Clin. Cancer Res. 10 (2004) 7304-7310
32. Tanaka E., Hashimoto Y., Ito T., Okumura T., Kan T., Watanabe G., et al. The clinical significance of aurora-A/STK15/BTAK expression in human esophageal squamous cell carcinoma. Clin. Cancer Res. 11 (2005) 1827-1834
33. Marumoto T., Zhang D., and Saya H. Aurora-A-a guardian of poles. Nat. Rev. Cancer 5 (2005) 42-50
34. Liu Q., Kaneko S., Yang L., Feldman R.I., Nicosia S.V., Chen J., and Cheng J.Q. Aurora-A abrogation of p53 DNA binding and transactivation activity by phosphorylation of serine 215. J. Biol. Chem. 279 (2004) 52175-52182
35. Bian Y.S., Osterheld M.C., Fontolliet C., Bosman F.T., and Benhattar J. p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in barrett's esophagus. Gastroenterology 122 (2002) 1113-1121
36. Schulmann K., Sterian A., Berki A., Yin J., Sato F., Xu Y., et al. Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk. Oncogene (2005) (April 11, Epub ahead of print)
37. Morales C.P., Gandia K.G., Ramirez R.D., Wright W.E., Shay J.W., and Spechler S.J. Characterisation of telomerase immortalised normal human oesophageal squamous cells. Gut 52 (2003) 327-333
38. Harada H., Nakagawa H., Oyama K., Takaoka M., Andl C.D., Jacobmeier B., et al. Telomerase induces immortalization of human esophageal keratinocytes without p16INK4a inactivation. Mol. Cancer Res. 1 (2003) 729-738
39. Veitonmaki N., Fuxe J., Hultdin M., Roos G., Pettersson R.F., and Cao Y. Immortalization of bovine capillary endothelial cells by hTERT alone involves inactivation of endogenous p16INK4A/pRb. Fed. Am. Soc. Exp. Biol. J. 17 (2003) 764-766
40. Yang H., Ou C.C., Feldman R.I., Nicosia S.V., Kruk P.A., and Cheng J.Q. Aurora-A kinase regulates telomerase activity through c-Myc in human ovarian and breast epithelial cells. Cancer Res. 64 (2004) 463-467
41. H. Zhang, Y.S. Jin, X.H. Chen, C. Jin, S. Law, S.W. Tsao, Y.L. Kwong, Cytogenetic aberrations in immortalization of esophageal epithelial cells, Cancer Genet. Cytogenet, in press.